Promega Corporation

AMPK (A1/B1/G1) Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human AMPK (combination of A1/B1/G1 subunits) was expressed by baculovirus in Sf9 insect cells using C-terminal His tags. AMPK is a heterotrimeric protein kinase consisting of an α catalytic subunit, and non-catalytic β and γ subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated and phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and β-hydroxy β-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating biosynthesi...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega GmbH only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

AMPK (A1/B1/G1) Kinase Enzyme System

Close Window

AMPK (A1/B1/G1) Kinase Enzyme System

 Components

10μg
- V1921 zł 2 852,00 Add to cart

AMPK (A1/B1/G1) Kinase Enzyme System

Close Window

AMPK (A1/B1/G1) Kinase Enzyme System

 Components

1mg
- V1922 zł 23 843,00 Add to cart

ADP-Glo™ Kinase Assay + AMPK (A1/B1/G1) Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + AMPK (A1/B1/G1) Kinase Enzyme System

 Components

  • AMPK (A1/B1/G1) Kinase Enzyme System

    V19211 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9021 zł 4 500,00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V1921, V1922, V9021 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9021 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9021 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9021 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9021 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9021 U.S. Pat. No. 8,183,007 and other patents pending.

V9021 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9021 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Prefer a different language?

Your country is set to Poland. Your language is set to polski. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.